Medical insurance price of Upadacitinib

Upadacitinib (Upadacitinib)The original drug has been launched in China, and has subsequently entered the scope of Class B medical insurance. Reimbursement is limited to eligible patients. Specifications< /span>The price of each box of 15mg*28 tablets may be around 3,000 RMB. The reimbursement ratio is different in different regions, and the price after reimbursement may be slightly different. For specific medical insurance information about the drug, patients can consult the local medical insurance bureau or hospital.

Upadatinib is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, nonradiographic axial spondylitis and objective signs of inflammation of one or more types Inadequate response to or intolerance to TNF blockers; also indicated for use in adult and pediatric patients 12 years and older with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled by other systemic medications, including biologics, or whose use is not recommended.

The European version of the original drug, which is marketed overseas, is sold under the brand nameRINVOQ. The price of 15mg*30 tablets is more than 20,000 yuan (the price may fluctuate due to the exchange rate), which is expensive. Cheaper upadatinib generic drugs are also sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 15mg*30 tablets produced by Bangladesh pharmaceutical factory is around 900 yuan (the price may fluctuate due to the exchange rate). For specific drug prices and drug information, consult a Yaode medical consultant.